A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

May 15, 2009

Interleukin-21 Tied to Control of Chronic Infections Like HIV

An immune signaling protein called interleukin-21 (IL-21) plays a critical role in the long-term control of chronic viral infections such as HIV disease, according to a study published online in Science and reported by ScienceDaily.

If CD4 cells are the directors of the body’s immune response, then “killer” CD8 cells do the dirty work of actually finding and destroying pathogens. Researchers have been certain that the CD4 and CD8 cells are able to communicate with one another, but until now, they haven’t known for sure what chemical proteins were necessary for that communication to take place.

To determine the role played by IL-21, Heidi Elsaesser, PhD, at the University of California in Los Angeles, bred mice whose immune cells are unable to make receptors for IL-21. They then infected the specially bred mice and normal mice with one of two strains of a virus. The first virus causes only a short-term infection, and the other causes a long-term chronic infection. Both types of mice managed to control the short-term infection, but the mice without IL-21 receptors couldn’t make enough CD8 cells to control the chronic infection.

“After the immune system loses CD8 T-cells, it’s unable to clear the virus,” said study coauthor, David Brooks, PhD. “This tells us that IL-21 is a critical player in the body’s fight against chronic infection.” These findings could help researchers understand how and why the immune system ultimately fails to control HIV in most people.

Search: IL-21, Interleukin 21, CD4, CD8, Killer cells, chronic infection


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    charliehunter
    San Francisco
    California


    guycmh328
    Columbus
    Ohio


    vinamarino94
    new york city
    New York


    cme_jamesd
    Huntington Beach
    California
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.